Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 26,681 | 21,267 | 14,001 | 13,646 | 12,699 |
| Operating Income | -26,681 | -21,267 | -14,001 | -13,646 | -12,699 |
| Other Income | 2,267 | 1,929 | 353 | 82 | 434 |
| Pre-tax Income | -24,414 | -19,338 | -13,648 | -13,564 | -12,265 |
| Income Tax | 30 | 43 | 28 | 28 | 27 |
| Net Income Continuous | -24,444 | -19,381 | -13,676 | -13,592 | -12,292 |
| Net Income | $-24,444 | $-19,381 | $-13,676 | $-13,592 | $-12,292 |
| EPS Basic Total Ops | -0.60 | -0.60 | -0.52 | -0.65 | -0.78 |
| EPS Basic Continuous Ops | -0.61 | -0.60 | -0.52 | -0.65 | -0.78 |
| EPS Diluted Total Ops | -0.60 | -0.60 | -0.52 | -0.65 | -0.78 |
| EPS Diluted Continuous Ops | -0.61 | -0.60 | -0.52 | -0.65 | -0.78 |
| EPS Diluted Before Non-Recurring Items | -0.60 | -0.60 | -0.52 | -0.65 | -0.78 |
| EBITDA(a) | $-27,985 | $-22,460 | $-13,987 | $-13,461 | $-12,682 |